Aggregated
58% success rate- Bullish
- 12
- Hold
- 18
- Bearish
- 0
UBS
A UBS analyst with 36 tracked ratings across 30 distinct tickers has a 58.3% success rate on the captured sample, primarily issuing 9 hold ratings and 8 bullish ratings across two covered sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| ENGN | 2026-05-14 | hold | $2.00 | Aggregated |
| NBTX | 2026-05-01 | hold | $30.00 | Aggregated |
| ENGN | 2025-11-12 | hold | $10.00 | Aggregated |
| ENGNENGENE HOLDINGS INC | 2025-11-12 | hold | $10.00 | Aggregated |
| VRTX | 2025-08-05 | buy | $553.00 | Aggregated |
| VRTXVERTEX PHARMACEUTICALS, INC. | 2025-08-05 | unknown | $553.00 | Aggregated |
| PTCT | 2025-07-29 | buy | $80.00 | Aggregated |
| PTCTPTC THERAPEUTICS INC | 2025-07-29 | unknown | $80.00 | Aggregated |
| RCKT | 2025-06-17 | buy | $5.00 | Aggregated |
| RCKTROCKET PHARMACEUTICALS INC | 2025-06-17 | unknown | $5.00 | Aggregated |
| ALXO | 2025-05-21 | buy | $1.00 | Aggregated |
| ALXOALX ONCOLOGY HOLDINGS INC | 2025-05-21 | unknown | $1.00 | Aggregated |
| IMVT | 2025-04-22 | hold | $17.00 | Aggregated |
| IMVTIMMUNOVANT INC | 2025-04-22 | hold | $17.00 | Aggregated |
| AMGN | 2025-04-14 | hold | $319.00 | Aggregated |
| AMGNAMGEN INC. | 2025-04-14 | hold | $319.00 | Aggregated |
| ABOS | 2025-03-28 | buy | $4.00 | Aggregated |
| ENGN | 2025-02-14 | hold | $7.00 | Aggregated |
| PFE | 2025-02-05 | hold | $28.00 | Aggregated |
| PFEPFIZER INC. | 2025-02-05 | hold | $28.00 | Aggregated |
| ALXO | 2025-01-27 | buy | $2.20 | Aggregated |
| MRK | 2025-01-08 | buy | $120.00 | Aggregated |
| MRKMERCK & CO INC | 2025-01-08 | unknown | $120.00 | Aggregated |
| GILD | 2024-11-21 | hold | $96.00 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 2024-11-21 | hold | $96.00 | Aggregated |
| BIIB | 2024-10-03 | hold | $202.00 | Aggregated |
| BIIBBIOGEN INC | 2024-10-03 | hold | $202.00 | Aggregated |
| ALXO | 2024-08-16 | buy | $4.00 | Aggregated |
| ABOS | 2024-08-15 | buy | $6.00 | Aggregated |
| BTAI | 2024-08-09 | hold | $1.00 | Aggregated |
| REGN | 2024-04-17 | buy | $1099.00 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 2024-04-17 | unknown | $1099.00 | Aggregated |
| BTAI | 2024-02-21 | hold | $4.00 | Aggregated |
| BTAIBIOXCEL THERAPEUTICS INC | 2024-02-21 | hold | $4.00 | Aggregated |
| PFE | 2023-10-20 | hold | $34.00 | Aggregated |
| SRPT | 2023-05-15 | buy | $173.00 | Aggregated |
| SRPTSAREPTA THERAPEUTICS INC | 2023-05-15 | unknown | $173.00 | Aggregated |
| LLY | 2022-12-15 | buy | $420.00 | Aggregated |
| LLYLILLY(ELI) & CO | 2022-12-15 | unknown | $420.00 | Aggregated |
| OMER | 2022-12-08 | hold | $2.00 | Aggregated |
| OMEROMEROS CORPORATION | 2022-12-08 | hold | $2.00 | Aggregated |
| PROK | 2022-10-18 | buy | $18.00 | Aggregated |
| PROKPROKIDNEY CORP - ORDINARY SHARES - CLASS A | 2022-10-18 | unknown | $18.00 | Aggregated |
| ABBV | 2022-08-01 | hold | $146.00 | Aggregated |
| ABBVABBVIE INC | 2022-08-01 | hold | $146.00 | Aggregated |
| CCCC | 2022-04-18 | buy | $26.00 | Aggregated |
| CCCCC4 THERAPEUTICS INC | 2022-04-18 | unknown | $26.00 | Aggregated |
| CADL | 2021-08-23 | buy | $9.00 | Aggregated |
| CADLCANDEL THERAPEUTICS INC | 2021-08-23 | unknown | $9.00 | Aggregated |
| ABOS | 2021-07-26 | buy | $27.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| ENGN | 4 | 2026-05-14 | Aggregated |
| NBTX | 1 | 2026-05-01 | Aggregated |
| ENGNENGENE HOLDINGS INC | 1 | 2025-11-12 | Aggregated |
| VRTX | 2 | 2025-08-05 | Aggregated |
| VRTXVERTEX PHARMACEUTICALS, INC. | 1 | 2025-08-05 | Aggregated |
| PTCT | 3 | 2025-07-29 | Aggregated |
| PTCTPTC THERAPEUTICS INC | 1 | 2025-07-29 | Aggregated |
| RCKT | 3 | 2025-06-17 | Aggregated |
| RCKTROCKET PHARMACEUTICALS INC | 1 | 2025-06-17 | Aggregated |
| ALXO | 5 | 2025-05-21 | Aggregated |
| ALXOALX ONCOLOGY HOLDINGS INC | 1 | 2025-05-21 | Aggregated |
| IMVT | 2 | 2025-04-22 | Aggregated |
| IMVTIMMUNOVANT INC | 1 | 2025-04-22 | Aggregated |
| AMGN | 1 | 2025-04-14 | Aggregated |
| AMGNAMGEN INC. | 1 | 2025-04-14 | Aggregated |
| ABOS | 4 | 2025-03-28 | Aggregated |
| PFE | 2 | 2025-02-05 | Aggregated |
| PFEPFIZER INC. | 1 | 2025-02-05 | Aggregated |
| MRK | 2 | 2025-01-08 | Aggregated |
| MRKMERCK & CO INC | 1 | 2025-01-08 | Aggregated |
| GILD | 1 | 2024-11-21 | Aggregated |
| GILDGILEAD SCIENCES, INC. | 1 | 2024-11-21 | Aggregated |
| BIIB | 1 | 2024-10-03 | Aggregated |
| BIIBBIOGEN INC | 1 | 2024-10-03 | Aggregated |
| BTAI | 3 | 2024-08-09 | Aggregated |
| REGN | 2 | 2024-04-17 | Aggregated |
| REGNREGENERON PHARMACEUTICALS, INC. | 1 | 2024-04-17 | Aggregated |
| BTAIBIOXCEL THERAPEUTICS INC | 1 | 2024-02-21 | Aggregated |
| SRPT | 2 | 2023-05-15 | Aggregated |
| SRPTSAREPTA THERAPEUTICS INC | 1 | 2023-05-15 | Aggregated |
| LLY | 2 | 2022-12-15 | Aggregated |
| LLYLILLY(ELI) & CO | 1 | 2022-12-15 | Aggregated |
| OMER | 1 | 2022-12-08 | Aggregated |
| OMEROMEROS CORPORATION | 1 | 2022-12-08 | Aggregated |
| PROK | 3 | 2022-10-18 | Aggregated |
| PROKPROKIDNEY CORP - ORDINARY SHARES - CLASS A | 1 | 2022-10-18 | Aggregated |
| ABBV | 1 | 2022-08-01 | Aggregated |
| ABBVABBVIE INC | 1 | 2022-08-01 | Aggregated |
| CCCC | 2 | 2022-04-18 | Aggregated |
| CCCCC4 THERAPEUTICS INC | 1 | 2022-04-18 | Aggregated |
| CADL | 2 | 2021-08-23 | Aggregated |
| CADLCANDEL THERAPEUTICS INC | 1 | 2021-08-23 | Aggregated |
| ABOSACUMEN PHARMACEUTICALS INC | 1 | 2021-07-26 | Aggregated |